达博辛P是一种印度Daboia russelii毒素的脂酶A2,可以调节血栓介导的血小板聚合
Rafika Yasmin1, Shankar Chanchal2, Mohammad Zahid Ashraf2
1Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, Assam, India.
Journal of biochemical and molecular toxicology
|July 19, 2023
概括
来自拉塞尔蛇毒的达博辛P抑制了由血栓激发的血小板聚合. 这种蛇毒蛋白与血栓结合,阻断其与血小板受体的相互作用,影响血液凝结.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 已知Daboxin P是一种来自Daboia russellii毒素的蛋白质,通过向X因子和XA因子,影响血液凝固级联.
- 血小板聚合是血液静止和血栓形成的关键过程,其失调可能导致各种心血管疾病.
研究的目的:
- 为了研究达博辛P对不同激动剂诱导的血小板聚合的影响.
- 阐明达博辛P抑制血栓诱导的血小板聚合的机制.
主要方法:
- 在体外测试测量使用各种激动剂 (血栓,原蛋白,ADP,酸) 的达博辛P抑制血小板聚合的测试.
- 剂量反应研究,以确定因血栓诱导的聚合而产生的抗聚合剂量 (AD50).
- 测量血小板中由血栓介导的流量.
- 在基分子对接研究预测Daboxin P和血栓蛋白之间的结合相互作用.
- 生物物理方法,包括光光谱学和拉下测试,以确认达博P-血结合.
主要成果:
- 达博辛P显著抑制了由血栓激发的血小板聚合,AD50为55.166nM.
- 观察到原诱导聚合的部分抑制 (50%),而ADP和酸诱导的聚合没有受到影响.
- 达博辛P降低了血小板中通过血栓介导的流入.
- 在和实验数据证实了Daboxin P与血栓的直接结合,阻断其与血小板受体的相互作用.
结论:
- 达博辛P是一种强有力的抑制剂,可以抑制血栓诱导的血小板聚合.
- 达博辛P的抗血小板活性主要通过直接与血栓结合来调节,从而防止其与血小板表面受体的相互作用.
- 这些发现突出了达博辛P作为对血栓性疾病的潜在治疗药物.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
563
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
563
Anticoagulant Drugs: Low-Molecular-Weight Heparins
757
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
757
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
708
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
708
Formation of the Platelet Plug
6.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.7K
Clot Retraction and Fibrinolysis
6.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.5K


